Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Claritev (MultiPlan) 2025 Outlook: Expects Revenues To Be (2)% To Flat YoY, And Sees Adj. EBITDA Margin Of 62.5%-63.5%

Author: Benzinga Newsdesk | February 25, 2025 07:06am

2025 Financial Guidance1

Financial Metric  Full Year 2025 Guidance
Revenues  (2)% to flat from FY 2024
Adjusted EBITDA Margin1  62.5% to 63.5%
Capital expenditures  $155 million to $165 million
Effective tax rate  25% to 28%
Free Cash Flow  $(65) to $(75) million

Posted In: MPLN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist